Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVVD Invivyd, Inc.

休市中 12-26 16:00:00 EST

2.69

-0.12

-4.27%

盘后2.70

+0.01+0.37%

19:21 EST

最高2.85	最低2.66	成交量237.64万
今开2.82	昨收2.81	日振幅6.94%
总市值7.45亿	流通市值5.49亿	总股本2.77亿
成交额653.80万	换手率1.16%	流通股本2.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":2.69,"timestamp":1766782800000,"preClose":2.81,"halted":0,"volume":2376403,"hourTrading":{"tag":"盘后","latestPrice":2.7,"preClose":2.69,"latestTime":"19:21 EST","volume":5744,"amount":15603.9325,"timestamp":1766794862054},"delay":0,"floatShares":204000000,"shares":277064852,"eps":-0.451489,"marketStatus":"休市中","change":-0.12,"latestTime":"12-26 16:00:00 EST","open":2.82,"high":2.85,"low":2.655,"amount":6537963.2605642,"amplitude":0.069395,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.451489,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766998800000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":2.81,"preHourTrading":{"tag":"盘前","latestPrice":2.7601,"preClose":2.81,"latestTime":"09:28 EST","volume":2994,"amount":8399.5122102,"timestamp":1766759315294},"postHourTrading":{"tag":"盘后","latestPrice":2.7,"preClose":2.69,"latestTime":"19:21 EST","volume":5744,"amount":15603.9325,"timestamp":1766794862054},"volumeRatio":0.27171103632098076,"impliedVol":0.9009,"impliedVolPercentile":0.284},"requestUrl":"/m/hq/s/IVVD","defaultTab":"news","newsList":[{"id":"1161114265","title":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=1161114265","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161114265?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:03","pubTimestamp":1766491396,"startTime":"0","endTime":"0","summary":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2586089304","title":"Invivyd, Inc.盘中异动 急速跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586089304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586089304?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:30","pubTimestamp":1764081051,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时30分，Invivyd, Inc.股票出现异动，股价大幅下挫5.42%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、Lunai Bioworks Inc.、Pasithea Therapeutics Corp.较为活跃，换手率分别为204.03%、126.16%、18.79%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.、Cardio Diagnostics Holdings Inc.，振幅分别为12.15%、7.95%、6.92%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"1134589274","title":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1134589274","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134589274?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IVVD"],"gpt_icon":0},{"id":"1191384298","title":"Invivyd 第三季度每股收益为 -0.06 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191384298","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191384298?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571449,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd 第三季度收入为 1312.9 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"1172620322","title":"Invivyd第三季度每股收益为-0.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172620322","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172620322?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:16","pubTimestamp":1762431395,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd第三季度营收为1312.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"1117108328","title":"Invivyd宣布获得美国IND批准，并与美国FDA就预防新冠疫苗替代抗体Vyd2311的关键临床项目达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1117108328","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117108328?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748601,"startTime":"0","endTime":"0","summary":"Invivyd宣布获得美国IND批准，并与美国FDA就预防新冠疫苗替代抗体Vyd2311的关键临床项目达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"1148205802","title":"Invivyd Inc：Declaration和Liberty临床试验预计2025年底启动，主要数据预期2026年中期公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1148205802","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148205802?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748588,"startTime":"0","endTime":"0","summary":"Invivyd Inc宣布，公司的Declaration和Liberty临床试验计划在2025年底前后开始进行。该公司预计相关试验的主要临床数据将在2026年中期对外公布。\n这两项临床试验的启动标志着Invivyd Inc在其研发管线推进方面的重要里程碑，市场将密切关注试验进展及后续数据发布情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"1193586295","title":"Invivyd, Inc.任命Paul B. Bolno医学博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1193586295","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193586295?lang=zh_cn&edition=full","pubTime":"2025-09-25 06:33","pubTimestamp":1758753216,"startTime":"0","endTime":"0","summary":"9月24日消息，Invivyd, Inc.宣布任命Paul B. Bolno医学博士为公司董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2568428548","title":"Invivyd, Inc.盘中异动 下午盘快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568428548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568428548?lang=zh_cn&edition=full","pubTime":"2025-09-18 02:44","pubTimestamp":1758134671,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日02时44分，Invivyd, Inc.股票出现异动，股价大幅下跌5.16%。截至发稿，该股报1.20美元/股，成交量98.0307万股，换手率0.47%，振幅6.26%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509180244319534a212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509180244319534a212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2567018301","title":"Invivyd, Inc.盘中异动 早盘急速下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567018301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567018301?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:36","pubTimestamp":1757943374,"startTime":"0","endTime":"0","summary":"北京时间2025年09月15日21时36分，Invivyd, Inc.股票出现波动，股价快速跳水5.59%。截至发稿，该股报1.35美元/股，成交量40.2047万股，换手率0.19%，振幅3.19%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213615a4c79024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213615a4c79024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2561496135","title":"美股周四早盘生物制药公司Invivyd（IVVD）股价重挫18%%此前该公司宣布通过证券发行筹集5000万美元资金。这笔","url":"https://stock-news.laohu8.com/highlight/detail?id=2561496135","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561496135?lang=zh_cn&edition=full","pubTime":"2025-08-21 22:12","pubTimestamp":1755785542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IVVD","161027","BK4139","BK4539"],"gpt_icon":0},{"id":"2561648211","title":"Invivyd, Inc.盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561648211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561648211?lang=zh_cn&edition=full","pubTime":"2025-08-20 23:21","pubTimestamp":1755703262,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日23时21分，Invivyd, Inc.股票出现波动，股价急速拉升5.08%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Propanc Biopharma, Inc.涨幅较大，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为3182.31%、2408.68%、345.68%，振幅较大的相关个股有Tharimmune, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Novabay Pharmaceuticals, Inc.，振幅分别为133.33%、100.00%、50.02%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820232102a4944c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820232102a4944c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2558667463","title":"Invivyd, Inc.盘中异动 股价大跌5.14%报0.757美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558667463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558667463?lang=zh_cn&edition=full","pubTime":"2025-08-12 02:43","pubTimestamp":1754937803,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日02时43分，Invivyd, Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报0.757美元/股，成交量36.3305万股，换手率0.30%，振幅6.44%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081202432394dd2fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081202432394dd2fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2558574131","title":"Invivyd, Inc.盘中异动 临近收盘股价大涨5.43%报0.795美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558574131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558574131?lang=zh_cn&edition=full","pubTime":"2025-08-09 03:45","pubTimestamp":1754682320,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日03时45分，Invivyd, Inc.股票出现波动，股价大幅上涨5.43%。截至发稿，该股报0.795美元/股，成交量62.1717万股，换手率0.52%，振幅7.95%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为1.20%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809034520973c74b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809034520973c74b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2557134567","title":"Invivyd, Inc.盘中异动 急速拉升5.38%报0.756美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557134567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557134567?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:26","pubTimestamp":1754580379,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时26分，Invivyd, Inc.股票出现波动，股价快速上涨5.38%。截至发稿，该股报0.756美元/股，成交量78.5778万股，换手率0.66%，振幅6.97%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807232619a47b4fbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807232619a47b4fbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2557231344","title":"Invivyd, Inc.盘中异动 大幅拉升5.00%报0.764美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557231344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557231344?lang=zh_cn&edition=full","pubTime":"2025-08-06 00:38","pubTimestamp":1754411901,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时38分，Invivyd, Inc.股票出现波动，股价大幅上涨5.00%。截至发稿，该股报0.764美元/股，成交量39.669万股，换手率0.33%，振幅4.48%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为3.01%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806003822a476f8b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806003822a476f8b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2555021689","title":"Invivyd, Inc.盘中异动 快速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555021689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555021689?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:26","pubTimestamp":1753903581,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时26分，Invivyd, Inc.股票出现异动，股价急速下跌5.17%。截至发稿，该股报0.765美元/股，成交量38.3775万股，换手率0.32%，振幅5.11%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032621a6ca23f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032621a6ca23f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2555246709","title":"Invivyd, Inc.盘中异动 临近收盘快速拉升5.01%报0.824美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555246709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555246709?lang=zh_cn&edition=full","pubTime":"2025-07-29 03:45","pubTimestamp":1753731916,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时45分，Invivyd, Inc.股票出现异动，股价快速拉升5.01%。截至发稿，该股报0.824美元/股，成交量117.733万股，换手率0.98%，振幅3.40%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290345169723c8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290345169723c8fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"2552438140","title":"Invivyd, Inc.盘中异动 大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552438140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552438140?lang=zh_cn&edition=full","pubTime":"2025-07-17 23:54","pubTimestamp":1752767674,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时54分，Invivyd, Inc.股票出现异动，股价大幅拉升5.08%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Imunon, Inc.较为活跃，换手率分别为921.02%、498.99%、221.13%，振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Clearside Biomedical, Inc.，振幅分别为148.12%、81.11%、61.99%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717235434a6b030a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717235434a6b030a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2551193166","title":"Invivyd, Inc.盘中异动 早盘快速下挫5.02%报0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551193166?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:34","pubTimestamp":1752590053,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时34分，Invivyd, Inc.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报0.690美元/股，成交量14.9187万股，换手率0.12%，振幅5.01%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715223413a44ca77c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715223413a44ca77c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":0.1696},{"period":"1month","weight":0.1545},{"period":"3month","weight":1.4018},{"period":"6month","weight":2.7027},{"period":"1year","weight":4.0716},{"period":"ytd","weight":5.0709}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司，其使命是快速、永久地提供基于抗体的疗法，以保护脆弱人群免受流行病毒威胁的破坏性后果，从SARS-CoV-2开始。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进快速、连续产生新的单克隆抗体（“MAB”），以跟上不断演变的病毒威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.131727},{"month":2,"riseRate":0.25,"avgChangeRate":0.440438},{"month":3,"riseRate":0.25,"avgChangeRate":-0.244287},{"month":4,"riseRate":0.25,"avgChangeRate":-0.228751},{"month":5,"riseRate":0.75,"avgChangeRate":0.245954},{"month":6,"riseRate":0.25,"avgChangeRate":-0.236507},{"month":7,"riseRate":0.75,"avgChangeRate":0.147422},{"month":8,"riseRate":0.75,"avgChangeRate":0.158597},{"month":9,"riseRate":0.6,"avgChangeRate":0.03577},{"month":10,"riseRate":0.4,"avgChangeRate":0.071726},{"month":11,"riseRate":0.4,"avgChangeRate":0.062538},{"month":12,"riseRate":0.4,"avgChangeRate":0.026896}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}